CD8A and neoplasm: i.t. injection of VV (daily for 5 days) enhanced the CD3+ T cell, CD8+ T cell, and B8R-specific CD8+ T cell infiltration into the tumor, and this effect was greater in pre-immunized compared with naive mice (Figures 2B–2D).